| Literature DB >> 21053939 |
Everett M Stone1, Lynne Chantranupong, George Georgiou.
Abstract
The active sites of eukaryotic arginase enzymes are strictly conserved, especially the first- and second-shell ligands that coordinate the two divalent metal cations that generate a hydroxide molecule for nucleophilic attack on the guanidinium carbon of l-arginine and the subsequent production of urea and l-ornithine. Here by using comprehensive pairwise saturation mutagenesis of the first- and second-shell metal ligands in human arginase I, we demonstrate that several metal binding ligands are actually quite tolerant to amino acid substitutions. Of >2800 double mutants of first- and second-shell residues analyzed, we found more than 80 unique amino acid substitutions, of which four were in first-shell residues. Remarkably, certain second-shell mutations could modulate the binding of both the nucleophilic water/hydroxide molecule and substrate or product ligands, resulting in activity greater than that of the wild-type enzyme. The data presented here constitute the first comprehensive saturation mutagenesis analysis of a metallohydrolase active site and reveal that the strict conservation of the second-shell metal binding residues in eukaryotic arginases does not reflect kinetic optimization of the enzyme during the course of evolution.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21053939 PMCID: PMC2998210 DOI: 10.1021/bi101542t
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162
Figure 1Depiction of the active site of hArgI with first-shell metal ligands (red) and second-shell ligands (blue) coordinating two metal cations necessary for activity.
Scheme 1High-Throughput Screening and Analysis
(a) Colonies harboring plasmids containing mutagenized hArgI fused to an N-terminally encoded His6 tag are picked into 96-well culture plates for expression. (b) Microtiter scale cultures are lysed and screened for activity. (c) Active clones are grown at the 50 mL scale. (d) Cells are pelleted and lysed with B-PER. (e) Soluble fractions are incubated with IMAC beads followed by elution. (f) After being heat incubated with Co2+, the resulting protein is buffer exchanged using a centrifugal device. (g) A SDS−PAGE gel is run to assess protein yield and purity. (h) The rate of hydrolysis of l-Arg is measured in triplicate in 96-well plates. (i) The data are plotted and fit to obtain apparent V/K values.
Steady-State Kinetic Characterization of Select hArgI Variantsa
| amino acid replacing D181 | amino acid replacing S230 | |||
|---|---|---|---|---|
| Cobalt(II) | ||||
| − | Gly | 200 ± 7 | 0.08 ± 0.01 | 2600 ± 420 |
| − | Cys | 327 ± 12 | 0.15 ± 0.02 | 2180 ± 360 |
| − | Thr | 315 ± 13 | 0.16 ± 0.02 | 1970 ± 370 |
| Glu | Ala | 220 ± 7 | 0.15 ± 0.02 | 1470 ± 210 |
| Ser | − | 388 ± 13 | 0.28 ± 0.03 | 1390 ± 190 |
| Asn | − | 387 ± 17 | 0.30 ± 0.04 | 1290 ± 230 |
| Glu | − | 344 ± 8 | 0.27 ± 0.02 | 1270 ± 110 |
| wt | wt | 240 ± 14 | 0.19 ± 0.04 | 1260 ± 330 |
| Asn | Gly | 247 ± 11 | 0.21 ± 0.03 | 1180 ± 220 |
| Ser | Gly | 180 ± 8 | 0.19 ± 0.03 | 950 ± 200 |
| Asp | 140 ± 3 | 0.15 ± 0.01 | 930 ± 80 | |
| Manganese(II) | ||||
| − | Gly | 266 ± 10 | 0.80 ± 0.1 | 330 ± 50 |
| Asn | Gly | 517 ± 11 | 2.8 ± 0.2 | 185 ± 17 |
| − | Cys | 285 ± 22 | 2.1 ± 0.4 | 136 ± 36 |
| − | − (wt) | 300 ± 12 | 2.3 ± 0.3 | 130 ± 20 |
| Asn | − | 360 ± 24 | 3.0 ± 0.5 | 120 ± 15 |
All enzymes were heat activated with Co2+ or Mn2+ as indicated.
From ref (6).
Required excess Co2+ for measuring activity.
Significantly different from that of wt (p < 0.05).
pH Rate Dependence of Select hArgI Variants
| p | p | |
|---|---|---|
| pH Dependence of | ||
| Mn-hArgI | 8.1 ± 0.1 | not applicable |
| Mn-hArgI-D181N/S230G | 7.7 ± 0.1 | not applicable |
| pH Dependence of | ||
| Mn-hArgI | 8.5 ± 0.1 | 10.9 ± 0.2 |
| Mn-hArgI-D181N/S230G | 8.4 ± 0.1 | 9.9 ± 0.1 |
| Co-hArgI-S230C | 7.8 ± 0.1 | 9.0 ± 0.1 |
| Co-hArgI | 7.5 ± 0.1 | 9.6 ± 0.1 |
| Co-hArgI-D181N | 7.4 ± 0.1 | 9.4 ± 0.1 |
| Co-hArgI-S230G | 7.0 ± 0.1 | 9.7 ± 0.1 |
| Co-hArgI-D181N/S230G | 7.0 ± 0.1 | 9.4 ± 0.1 |
From ref (6).
Product Inhibition Constants of Select hArgI Variants
| Mn-hArgI | 2.3 ± 0.1 |
| Mn-hArgI-D181N | 2.4 ± 0.2 |
| Mn-hArgI-D181N/S230G | 1.0 ± 0.25 |
| Mn-hArgI-S230G | 0.7 ± 0.1 |
| Co-hArgI-D181N | 0.11 ± 0.02 |
| Co-hArgI-D181N/S230G | 0.09 ± 0.02 |
| Co-hArgI | 0.08 ± 0.02 |
| Co-hArgI-S230G | 0.05 ± 0.01 |
From ref (6).
Figure 2Sequence alignments of hArgI and arginases from several bacterial species showing the absolutely conserved first-shell ligand residues (red) and the highly conserved second-shell ligand residues (blue).